Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,21127,858,1.50 [1.21-1.84],0.0001465930197173
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21078,168,2.17 [1.41-3.34],0.0004243103963385
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22810,172,1.06 [0.66-1.68],0.8187456207951778
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16092,642,1.76 [1.39-2.24],3.286309095251972e-06
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22749,111,1.05 [0.59-1.88],0.8719148075767547
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21848,76,1.85 [0.99-3.43],0.0527991629855418
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23959,110,1.08 [0.60-1.93],0.8002471287644396
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23952,73,0.81 [0.39-1.69],0.5733450713468704
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21301,52,2.18 [1.06-4.46],0.0339742427493116
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23403,105,2.11 [1.28-3.49],0.0033670194055842
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23363,65,1.43 [0.69-2.95],0.338865758880723
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24029,68,1.70 [0.89-3.24],0.1093025602076638
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other viral diseases,24002,85,1.34 [0.73-2.48],0.3470121922196828
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23999,82,1.35 [0.72-2.51],0.3500928663554036
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Mycoses,23710,56,0.86 [0.37-1.96],0.7123880423129497
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23012,371,1.58 [1.18-2.11],0.0021114196556631
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22758,117,2.03 [1.32-3.12],0.0012755521680731
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22894,253,1.69 [1.20-2.38],0.0029164405375303
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",19641,44,2.42 [1.22-4.78],0.0110140009042686
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19653,56,nan [nan-nan],
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19825,228,1.20 [0.79-1.80],0.3906923186067272
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19832,235,1.21 [0.81-1.81],0.347689001407761
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",20182,585,1.28 [0.99-1.64],0.0559905249104632
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19645,48,2.55 [1.55-4.20],0.0002403629002778
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21588,894,1.71 [1.41-2.08],7.258114478323744e-08
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23115,256,1.75 [1.25-2.46],0.00112806326142
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23731,100,1.73 [1.02-2.92],0.0409993389381259
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24112,81,1.85 [1.03-3.34],0.0393375907803941
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Rectum,23928,53,2.06 [1.06-4.01],0.0327538496957725
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24109,59,1.00 [0.44-2.25],0.995733771051147
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Stomach,24154,45,0.79 [0.30-2.03],0.6182373687161404
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm,23962,243,0.88 [0.59-1.32],0.5378970784403938
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24111,100,0.92 [0.50-1.72],0.7968574171355912
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,24109,93,1.00 [0.53-1.91],0.9895792420269888
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24044,62,0.96 [0.44-2.11],0.9208039864742512
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Haemangioma, any site",24046,61,1.00 [0.45-2.20],0.9912258294769024
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Melanocytic naevi,23961,234,1.00 [0.67-1.50],0.9953228712309796
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,24112,111,0.91 [0.50-1.63],0.7430497078638301
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Other benign neoplasms of skin,24014,199,1.12 [0.73-1.72],0.5914773518922483
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm of breast,24095,121,1.07 [0.62-1.86],0.8030880254709445
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Leiomyoma of uterus,23665,885,1.07 [0.87-1.31],0.5358917039805033
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22965,237,1.43 [0.99-2.06],0.0540705399614207
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22730,388,1.61 [1.21-2.16],0.0012776418429486
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22730,388,1.61 [1.21-2.16],0.0012776418429486
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),21393,350,1.95 [1.45-2.62],1.0124312978075948e-05
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23633,87,1.37 [0.74-2.56],0.3170140311666406
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23856,86,1.40 [0.79-2.49],0.2518349035742013
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,20065,773,1.59 [1.28-1.98],2.998425181821388e-05
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22163,771,1.78 [1.45-2.20],4.8176393972960095e-08
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,22539,95,1.75 [1.02-3.01],0.0423779058026633
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23262,48,2.35 [1.32-4.19],0.0035998785493668
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22529,85,1.69 [0.94-3.02],0.0795042829757692
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,22800,356,1.29 [0.93-1.80],0.1266305187290161
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22790,346,1.29 [0.93-1.81],0.1298199162347492
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22368,160,1.06 [0.63-1.79],0.8156277468111002
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22370,157,1.04 [0.61-1.77],0.8787888945401807
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,19895,603,1.26 [0.97-1.65],0.0801806371617677
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19361,69,1.48 [0.72-3.07],0.2889249788529588
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,19854,562,1.28 [0.98-1.68],0.0732937080592482
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19340,48,1.08 [0.44-2.65],0.8699870859057814
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",19351,59,3.43 [2.20-5.36],5.75630792319109e-08
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Any mental disorder,20392,526,1.04 [0.79-1.37],0.7752672550806633
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19967,101,1.23 [0.67-2.28],0.5013843377811289
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23938,65,0.92 [0.45-1.86],0.8150871964895032
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23974,39,1.35 [0.69-2.62],0.380103722154922
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22892,33,0.72 [0.24-2.15],0.5514052987311175
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",24111,33,0.70 [0.24-2.04],0.5086972203464423
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",19899,33,0.73 [0.24-2.19],0.5727848429218885
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Alcohol dependence,22883,24,1.83 [0.58-5.81],0.3064912957060969
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Smoking dependency,22806,32,1.95 [0.70-5.48],0.2035802873226997
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19905,39,0.54 [0.19-1.50],0.2365951296717997
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20188,322,1.22 [0.86-1.72],0.2609846822616897
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Depression,22401,288,1.18 [0.83-1.69],0.3610049123263172
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Depression or dysthymia,20008,250,1.27 [0.86-1.87],0.2255262197716488
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19996,130,0.78 [0.45-1.35],0.3749988616893895
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Other anxiety disorders,22488,65,0.61 [0.28-1.33],0.2113610808489319
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Neurological diseases,20920,1424,1.22 [1.03-1.44],0.0194102636859765
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19145,170,1.37 [0.87-2.15],0.1762952749375564
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23981,140,1.22 [0.74-2.01],0.427389859641538
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23007,370,1.84 [1.40-2.41],1.2393734257165226e-05
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Epilepsy,22753,116,2.55 [1.73-3.74],1.8786408678005268e-06
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Migraine,22749,112,1.37 [0.78-2.40],0.2756405181034924
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23764,104,1.14 [0.63-2.06],0.6545479951987729
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23547,51,2.15 [1.11-4.15],0.0223751544794134
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other sleep disorders,22724,87,1.33 [0.70-2.54],0.3887134633945559
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Sleep apnoea,23797,62,1.16 [0.54-2.49],0.6992238528966633
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22948,731,1.00 [0.79-1.26],0.980298196192952
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22319,102,1.47 [0.87-2.48],0.1537146060264926
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22677,460,0.87 [0.65-1.17],0.3510067673775164
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23933,67,1.79 [0.99-3.23],0.0545313329463036
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Hemiplegia,23917,51,1.79 [0.91-3.53],0.0939023980638044
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other neurological diseases,23732,105,0.61 [0.33-1.14],0.1219963635920302
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23517,381,0.92 [0.67-1.27],0.6170221885106156
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23356,220,0.90 [0.59-1.38],0.6314839550023285
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23201,65,0.70 [0.32-1.53],0.3687862811305902
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23252,116,0.65 [0.36-1.17],0.1502827481314648
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23230,94,1.17 [0.62-2.19],0.6295487194948046
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20499,153,1.23 [0.74-2.06],0.4285336724792281
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,20713,367,0.99 [0.71-1.38],0.9331506863518528
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23245,155,0.92 [0.55-1.53],0.7456950943178806
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23928,29,1.84 [0.69-4.92],0.2264554265901931
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1550,29,1.23 [0.40-3.77],0.7160453577321421
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",22407,29,1.91 [0.73-5.00],0.1904321001084346
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23540,82,1.07 [0.54-2.13],0.8466268158071907
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23502,44,1.02 [0.40-2.60],0.9743360903674982
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23411,78,0.89 [0.44-1.81],0.7473254171785173
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23647,91,0.89 [0.46-1.70],0.7154403399487022
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,24041,111,1.18 [0.67-2.07],0.5745853313861907
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,23459,97,0.69 [0.36-1.32],0.2675000467914908
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,17759,2413,1.64 [1.42-1.89],9.752042607216435e-12
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23662,69,2.64 [1.61-4.32],0.0001124097609197
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, essential",18676,1768,1.55 [1.32-1.82],6.770468493500494e-08
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypertension,18692,1784,1.53 [1.31-1.80],1.1610609461478977e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16942,34,0.87 [0.29-2.60],0.8067890298724018
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22688,618,1.16 [0.90-1.50],0.2398268852438992
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Angina pectoris,22498,428,1.09 [0.80-1.48],0.5842226349395624
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23571,124,0.91 [0.52-1.59],0.745028554835406
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23638,191,0.95 [0.60-1.49],0.8173480962523051
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24092,24,0.52 [0.14-1.92],0.3273701253306839
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22150,80,1.05 [0.52-2.11],0.89934883856715
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22459,400,1.17 [0.85-1.59],0.3393303992566008
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23453,87,1.73 [0.95-3.12],0.0707391896807169
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23555,189,1.35 [0.88-2.09],0.1696031882991928
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23458,92,2.61 [1.68-4.06],1.8643345880318186e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23458,92,2.61 [1.68-4.06],1.8643345880318186e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16997,89,2.62 [1.66-4.12],3.225959867806767e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21024,33,1.59 [0.58-4.37],0.3693069436775089
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Conduction disorders,21056,65,1.59 [0.79-3.21],0.197822057153064
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14518,88,1.55 [0.84-2.86],0.1575170077449379
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,14669,239,2.76 [2.00-3.81],7.086133041564634e-10
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other arrhythmias,21035,44,1.57 [0.68-3.67],0.2932811219123333
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21041,50,1.36 [0.58-3.17],0.4742852327521378
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23439,88,2.16 [1.25-3.74],0.0058581311886666
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23473,115,1.23 [0.70-2.15],0.4661778002145413
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23509,86,1.32 [0.70-2.50],0.3947827084380032
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23570,74,1.25 [0.62-2.50],0.5320555220513529
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23285,60,1.08 [0.49-2.40],0.8414108015432468
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23319,94,1.48 [0.84-2.60],0.1713983049100182
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22749,113,1.11 [0.62-1.98],0.7235865829330649
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22726,90,1.34 [0.72-2.49],0.3584108533001298
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23964,89,1.37 [0.74-2.54],0.3153507791765741
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Varicose veins,23174,538,0.97 [0.74-1.27],0.8093962025421593
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypotension,23197,75,1.49 [0.77-2.88],0.2375001581141562
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,19640,1843,1.41 [1.21-1.64],7.852408479092082e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23959,114,1.39 [0.83-2.33],0.2079120004732486
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22746,178,1.53 [0.98-2.37],0.0587589221408359
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22731,163,1.50 [0.94-2.38],0.0860470346970362
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23351,203,1.19 [0.78-1.81],0.4251098936244457
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23347,199,1.15 [0.75-1.77],0.5150870717100795
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23482,493,1.12 [0.85-1.47],0.4241617810406669
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Chronic sinusitis,23093,104,1.48 [0.84-2.59],0.1745162083835811
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Nasal polyp,23061,72,1.02 [0.49-2.12],0.9536790108822868
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23301,312,1.05 [0.74-1.48],0.8008156339254686
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Deviated nasal septum,23110,121,1.40 [0.84-2.33],0.199433984049403
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11604,57,1.12 [0.48-2.62],0.7996281773780303
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21545,1017,1.24 [1.02-1.50],0.0270261692798306
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Early onset COPD,23245,136,1.61 [1.04-2.49],0.0337208184163571
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23262,153,1.53 [0.99-2.36],0.0565795832987298
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",23262,153,1.53 [0.99-2.36],0.0565795832987298
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",22326,874,1.17 [0.95-1.43],0.1470604552866077
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Asthma,17955,874,1.25 [1.00-1.54],0.0464068073773944
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",17794,874,1.26 [1.01-1.56],0.0373627552540833
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",17944,863,1.26 [1.02-1.57],0.0353137672766674
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23868,77,1.97 [1.06-3.68],0.0330406266068216
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Interstitial lung disease,22541,59,2.47 [1.40-4.38],0.0018633114238762
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23932,59,2.41 [1.35-4.30],0.0029819444622546
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22535,53,2.58 [1.42-4.68],0.0018543734283425
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pleural effusion,22542,73,2.17 [1.31-3.58],0.0024955476656481
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other diseases of pleura,22636,167,2.09 [1.46-3.01],6.435968530671872e-05
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23130,81,1.97 [1.20-3.24],0.0072968195474924
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16772,5263,1.27 [1.15-1.41],4.13738954040759e-06
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23649,420,1.31 [0.99-1.73],0.0578889832360246
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24115,91,0.92 [0.49-1.74],0.796188674166196
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Impacted teeth,24119,82,1.05 [0.54-2.02],0.8879910361143795
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Dental caries,23325,96,1.65 [1.00-2.70],0.0477871305516984
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23338,109,1.22 [0.70-2.14],0.4825752829623002
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,24106,101,0.84 [0.46-1.56],0.5844104721834058
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23329,100,1.81 [1.11-2.96],0.0176211626927758
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23068,69,0.63 [0.29-1.36],0.2428455292609312
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24028,44,0.49 [0.19-1.28],0.1438668407291142
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18285,194,1.13 [0.73-1.76],0.5762934876753139
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20116,2025,1.25 [1.08-1.44],0.0023636981521953
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Oesophagitis,18350,259,1.36 [0.94-1.97],0.1027230980631679
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18743,652,1.24 [0.97-1.57],0.0825290579872151
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18159,68,1.64 [0.89-3.04],0.1148451750757421
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18213,122,2.29 [1.50-3.49],0.0001174690169261
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Oesophageal obstruction,18126,35,2.96 [1.48-5.92],0.0021461992925743
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastric ulcer,18220,129,1.11 [0.64-1.90],0.7120669038898468
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Duodenal ulcer,18157,66,1.07 [0.50-2.30],0.8612756876745198
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24070,51,0.98 [0.41-2.34],0.9630916559076974
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Chronic gastritis,18207,116,1.47 [0.86-2.52],0.1564630800727164
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18825,734,1.19 [0.95-1.50],0.1333160423813759
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of appendix,24010,132,0.86 [0.50-1.47],0.5769095532438996
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Functional dyspepsia,18594,503,1.07 [0.80-1.41],0.6587623477318125
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18241,150,1.01 [0.61-1.69],0.9674813580449924
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,24030,126,1.24 [0.74-2.07],0.4068245401524604
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute appendicitis,23987,109,0.94 [0.52-1.70],0.8480641527518122
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Hernia,21630,1056,1.31 [1.08-1.58],0.0060158453419641
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Inguinal hernia,20632,58,1.90 [1.03-3.50],0.0399991405406913
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Umbilical hernia,20641,67,0.52 [0.24-1.14],0.1036536199043782
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Ventral hernia,20663,89,0.77 [0.39-1.50],0.4375166926561125
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,21420,846,1.46 [1.18-1.80],0.000389381085061
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23202,798,1.36 [1.10-1.67],0.0038289883978933
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of intestines,19183,1912,1.21 [1.04-1.40],0.01091293568324
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23855,58,2.42 [1.50-3.90],0.0002843004937355
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",24096,82,2.55 [1.69-3.87],9.77743347349958e-06
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Crohn disease,22486,82,2.55 [1.68-3.85],9.849821009915984e-06
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22464,60,2.76 [1.76-4.31],8.889266831759968e-06
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",24020,113,1.67 [1.02-2.73],0.0421581582087698
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Ulcerative colitis,22517,113,1.70 [1.04-2.77],0.0340305233244279
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22503,99,1.76 [1.05-2.94],0.030685263491902
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23083,679,1.26 [1.00-1.58],0.0490960077815688
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23073,669,1.23 [0.97-1.55],0.0819923676701392
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17361,90,1.22 [0.65-2.29],0.5336210324702497
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Intestinal stricture,23733,90,1.23 [0.66-2.31],0.5163835248656928
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17327,56,1.75 [0.90-3.41],0.0982385596349368
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,17859,588,1.23 [0.95-1.58],0.1180480236791751
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17482,211,1.25 [0.84-1.86],0.2810311869731344
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,17608,337,1.44 [1.06-1.96],0.0206518849641623
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Constipation,22686,302,1.36 [0.97-1.90],0.0724588914674278
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23700,113,1.37 [0.81-2.31],0.2381750001205438
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,17382,111,1.08 [0.61-1.90],0.7851945408947776
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,17312,41,0.87 [0.33-2.28],0.7819048456662937
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18049,778,1.24 [1.00-1.54],0.049649991706713
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of intestine,17474,203,1.13 [0.74-1.72],0.5729417961352885
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23686,99,1.56 [0.92-2.64],0.0975688184153455
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of liver,23469,87,2.93 [1.93-4.43],3.7162431232761113e-07
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of liver,23426,44,1.93 [0.97-3.84],0.0627541090347252
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22771,752,1.33 [1.07-1.66],0.0101691326063494
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Cholelithiasis,22646,627,1.33 [1.04-1.69],0.0214096650834924
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Cholecystitis,22134,115,1.43 [0.84-2.43],0.1915981907697104
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22077,58,1.13 [0.51-2.49],0.7616984418759483
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute pancreatitis,22070,51,2.83 [1.52-5.27],0.0009996125095867
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),24011,51,2.80 [1.50-5.24],0.0012222921795174
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22950,260,1.66 [1.19-2.30],0.0024770829808661
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22780,90,1.16 [0.62-2.19],0.6360348084300673
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Coeliac disease,22767,77,1.12 [0.56-2.24],0.7385403512227452
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22724,34,2.18 [1.19-4.01],0.0118734580766026
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22831,141,1.74 [1.14-2.66],0.0096688407874744
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,GI-bleeding,22823,133,1.65 [1.06-2.57],0.0276467796938354
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21380,1406,1.16 [0.98-1.38],0.0814022012200867
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23742,104,1.26 [0.71-2.26],0.428981418002578
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23756,396,1.09 [0.80-1.48],0.5827553401729857
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22766,596,1.14 [0.89-1.46],0.313525853301938
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23429,290,1.53 [1.09-2.15],0.0138538704408572
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23203,64,1.67 [0.83-3.34],0.150716661118959
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23325,186,1.44 [0.94-2.22],0.0947848204823549
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23884,77,0.98 [0.48-1.97],0.9459518608518136
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23862,55,1.41 [0.66-2.99],0.3762064384565262
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23849,42,1.69 [0.77-3.70],0.1889548850056746
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23923,50,0.42 [0.17-1.04],0.0604432631477616
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23920,47,0.42 [0.16-1.07],0.0701841128869781
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23411,51,0.42 [0.17-1.02],0.0547612699569677
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23667,307,1.22 [0.87-1.72],0.2446410804728049
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22253,83,1.04 [0.53-2.05],0.9048200997763056
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22302,132,1.40 [0.85-2.31],0.1905122351812239
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22265,95,1.53 [0.87-2.69],0.1359252694752883
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22395,225,1.01 [0.67-1.52],0.9756803953765274
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22373,203,1.07 [0.70-1.64],0.7632086299148404
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16994,3866,1.04 [0.92-1.17],0.5223573287617518
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18544,2222,0.95 [0.82-1.10],0.5062813134550526
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21680,1175,0.99 [0.82-1.19],0.9222280949951748
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16517,195,2.07 [1.47-2.92],3.3797852813321035e-05
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16778,456,1.30 [0.98-1.73],0.0704407229652718
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23648,187,2.16 [1.54-3.02],7.902165276267464e-06
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23662,172,2.33 [1.66-3.26],8.79514253000132e-07
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17393,1071,0.98 [0.80-1.21],0.8854997842150476
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",19762,1071,1.00 [0.82-1.23],0.9694186965585871
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16334,12,2.67 [0.60-11.83],0.1950978559643892
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23988,12,2.82 [0.70-11.34],0.143924078107868
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,16555,233,0.68 [0.44-1.04],0.0769180693661275
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16398,76,1.27 [0.63-2.56],0.5097271780139849
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,16592,270,1.27 [0.87-1.86],0.2224885707849052
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23970,140,1.44 [0.87-2.38],0.156426705358044
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,16741,419,0.78 [0.56-1.08],0.1337262292864733
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,16737,415,0.82 [0.60-1.14],0.242137776919581
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,17562,1240,0.81 [0.67-0.98],0.0338216991688612
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16422,100,0.48 [0.25-0.92],0.0274755477479017
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16690,368,0.73 [0.52-1.02],0.068376351097721
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16390,68,0.63 [0.29-1.41],0.2627121510368377
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16415,93,1.08 [0.56-2.07],0.8256418447784577
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16646,324,0.67 [0.46-0.96],0.0289320624899372
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16596,274,0.71 [0.48-1.05],0.0839818681719886
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17989,259,1.20 [0.83-1.75],0.3310021104080675
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23408,208,2.33 [1.70-3.19],1.5957814645603153e-07
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23282,82,3.18 [2.12-4.77],2.117500654718557e-08
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20688,77,0.71 [0.35-1.47],0.3624598759169845
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,20888,277,0.85 [0.58-1.25],0.4149385476844652
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,21516,905,0.92 [0.75-1.14],0.4620465055068811
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20804,193,0.73 [0.46-1.16],0.1840907273189138
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20681,70,1.40 [0.69-2.81],0.3517417328303654
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21329,718,0.99 [0.79-1.25],0.9448258125792502
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20655,44,0.53 [0.20-1.36],0.1848067476747762
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20821,210,1.21 [0.81-1.83],0.3508334453039606
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20699,88,1.29 [0.69-2.38],0.4228875482972092
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20689,78,1.60 [0.88-2.89],0.1221533724598357
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20742,131,1.36 [0.84-2.20],0.2110509300641698
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20682,71,1.32 [0.67-2.60],0.421767562541779
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20924,313,0.71 [0.49-1.01],0.0591378694799884
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20848,343,0.95 [0.68-1.34],0.7849904633205693
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20570,65,1.15 [0.54-2.46],0.7106833542183827
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20601,96,1.25 [0.67-2.32],0.4882729648498127
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20629,124,0.70 [0.39-1.24],0.2228146901633928
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20542,37,0.66 [0.23-1.89],0.4382045817332934
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20556,51,0.58 [0.23-1.44],0.2383435081104978
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20543,38,0.58 [0.20-1.67],0.3107486769005643
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20741,236,1.32 [0.90-1.93],0.1567100282314455
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20557,52,1.83 [0.93-3.59],0.0807036076687984
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20562,57,1.31 [0.60-2.87],0.4934530019039392
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20621,116,1.05 [0.59-1.85],0.8696394610760751
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20576,71,1.04 [0.51-2.15],0.9059735863322712
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20984,479,0.93 [0.70-1.24],0.6139306349642988
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20676,171,0.86 [0.53-1.40],0.5507227584554442
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20767,262,1.01 [0.69-1.48],0.9515194616021206
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,21728,214,1.47 [0.98-2.19],0.0599888722231657
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,21938,424,1.35 [1.01-1.80],0.0437491769358599
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,21549,35,1.21 [0.44-3.36],0.7141136134433785
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21565,51,1.35 [0.59-3.08],0.4808427800606711
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21608,94,1.44 [0.80-2.58],0.2213958302783838
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,19815,5383,1.01 [0.92-1.12],0.7715977436292558
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22118,156,0.94 [0.57-1.55],0.8144183750990611
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22001,39,0.63 [0.23-1.77],0.3838004823284338
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22293,27,1.97 [0.84-4.60],0.1178509659857008
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22296,30,1.45 [0.52-4.04],0.4738928261970575
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22296,30,1.43 [0.51-4.04],0.4984460818858706
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23937,113,1.17 [0.67-2.04],0.5901145552330511
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23845,54,1.08 [0.47-2.47],0.8540483831759415
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23908,84,1.19 [0.63-2.26],0.586033255984556
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23857,33,1.31 [0.48-3.57],0.5996624860976523
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22227,1101,1.02 [0.84-1.24],0.8253098396562446
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Cystitis,21235,109,1.63 [0.98-2.72],0.0617601266853682
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21201,75,0.85 [0.41-1.76],0.6631933383525781
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21270,144,1.44 [0.89-2.34],0.1413409924531617
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21208,82,1.08 [0.54-2.13],0.8293393821663331
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21996,870,1.02 [0.82-1.26],0.8631600889038837
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Disorders of breast,23883,425,1.00 [0.74-1.35],0.9926124673846336
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,23591,133,0.99 [0.58-1.69],0.9589753614346088
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,23602,144,0.87 [0.52-1.47],0.6130459657322505
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,23564,106,1.50 [0.89-2.53],0.1299027265236273
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,23818,487,0.95 [0.71-1.26],0.6980809841419201
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,23448,117,0.80 [0.45-1.44],0.4634979958838332
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,23546,215,1.16 [0.77-1.75],0.4777622601937634
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,22028,4030,0.95 [0.85-1.05],0.3139597334428361
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Endometriosis,18310,312,0.92 [0.65-1.32],0.6518543419578473
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,18086,88,0.72 [0.37-1.42],0.3442984922001656
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),18144,146,1.06 [0.64-1.76],0.8312050743939124
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18699,701,0.80 [0.63-1.03],0.0789494838864902
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,18347,349,0.77 [0.54-1.08],0.1258906288441177
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18835,837,0.99 [0.79-1.23],0.9022695530639084
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Uterine polyps,18271,273,1.09 [0.74-1.58],0.6690613656685729
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",18385,387,1.19 [0.87-1.63],0.2784936225222054
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,18086,88,1.42 [0.77-2.63],0.2646117053167692
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,18165,167,0.78 [0.47-1.27],0.312629663265159
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",24115,233,0.89 [0.59-1.34],0.5789302695303996
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,24125,221,0.89 [0.58-1.35],0.5747194007541544
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,24145,121,0.81 [0.46-1.43],0.4721222773689255
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",24136,133,0.82 [0.48-1.42],0.4846992015214744
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,18125,127,0.97 [0.56-1.70],0.926093438802214
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,18102,104,1.48 [0.84-2.62],0.1763682215264218
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,18125,127,0.93 [0.54-1.63],0.8094242472153472
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Irregular menses,24054,408,0.90 [0.66-1.22],0.4814056375327877
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",19181,1183,1.00 [0.83-1.21],0.99505318623102
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Menorrhagia,18771,773,1.12 [0.89-1.40],0.3308105268503427
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",24131,176,1.25 [0.80-1.93],0.3240439995187857
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,18407,409,0.82 [0.60-1.12],0.2091537425631203
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,18272,274,1.10 [0.76-1.59],0.6240411612169241
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,18795,797,1.25 [1.00-1.57],0.0509467326263854
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Female infertility,18086,88,0.98 [0.51-1.91],0.9629015407162064
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",18079,81,1.01 [0.50-2.00],0.9886490546653472
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,24141,733,0.90 [0.71-1.15],0.4129486968457061
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,24148,1014,0.87 [0.70-1.08],0.2070508420534096
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,24142,395,0.91 [0.66-1.24],0.5493245562808797
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,23858,111,1.02 [0.58-1.79],0.952239832857529
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,23904,157,1.17 [0.75-1.84],0.4888676702558534
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,23887,140,0.75 [0.45-1.27],0.2869144329418774
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",24158,144,0.88 [0.53-1.47],0.6291296831832519
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,24160,141,0.83 [0.49-1.40],0.4779253910303316
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,24157,365,0.97 [0.70-1.35],0.8572210629239575
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,23900,108,0.94 [0.53-1.69],0.8434990666051594
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,23995,203,0.74 [0.47-1.15],0.1770060679010483
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,23533,125,1.15 [0.68-1.94],0.5996044296403491
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,23580,172,1.04 [0.66-1.64],0.8595262149452867
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,23611,203,0.98 [0.64-1.50],0.929202937002608
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,23530,122,0.65 [0.36-1.16],0.1471054781792387
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,23523,115,0.89 [0.51-1.58],0.6990589924452384
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,23534,126,0.73 [0.42-1.28],0.2749043135651727
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,23326,192,0.73 [0.45-1.17],0.1853987835290091
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],23513,379,0.81 [0.58-1.13],0.2102521721784096
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,23696,562,0.90 [0.68-1.19],0.4552640522929471
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",24163,147,1.02 [0.62-1.67],0.9499987754705064
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,22934,113,1.02 [0.57-1.80],0.9562989427250256
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",23219,85,1.11 [0.58-2.11],0.7612474107597824
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,24168,289,0.64 [0.44-0.93],0.020904260993993
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,24102,223,0.52 [0.33-0.80],0.0028417451684011
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",24157,216,0.87 [0.57-1.33],0.5227510664240123
CLSTN3,Calsyntenin-3,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",24147,206,0.91 [0.59-1.40],0.6795620603152508
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23906,42,0.63 [0.24-1.69],0.362499638470338
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Falls/tendency to fall,21629,546,1.20 [0.92-1.56],0.1720847909421929
